KLK3 and cancer: On the other hand, PSA levels of the protective and therapeutic groups significantly reduced to 24.33 ± 1.34 and 20.17 ± 1.19 ng/mL, with a 72.11 and 76.88% reduction percentage than PSA of the cancer control (P ≤ 0.05).